Overview

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

Status:
Completed
Trial end date:
2019-10-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to examine the effect of multiple doses of AG-881 on the pharmacokinetics (PK) of a single dose of lamotrigine in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Agios Pharmaceuticals, Inc.
Treatments:
Anticonvulsants
Lamotrigine